Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Adds Four Members to Advisory Board, Renews Executive Contracts
LXRP recently added multiple highly respected experts to its scientific advisory board The company is readying for growth by ensuring executive continuity LXRP continues to conduct research regarding oral nicotine Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has bolstered its future growth prospects by adding four new members to its scientific advisory board and renewing executive contracts with three-year compensation deals for key officers, including CEO Chris Bunka and President John Docherty. The agreements and new advisory board team members offer LXRP and its shareholders seamless executive continuity (http://ibn.fm/oBuUZ). New members of LXRP’s scientific advisory board include (http://ibn.fm/KSdJ3): Dr. Dwayne Godwin, dean…